---
document_datetime: 2023-09-21 20:20:07
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tivicay-epar-all-authorised-presentations_en.pdf
document_name: tivicay-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.613277
conversion_datetime: 2025-12-26 21:06:28.768902
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

## Annex A

<!-- image -->

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                              | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|--------------------------------------------------|-------------|
| EU/1/13/892/001  | Tivicay           | 50 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)                                    | 30 tablets  |
| EU/1/13/892/002  | Tivicay           | 50 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)                                    | 90 tablets  |
| EU/1/13/892/003  | Tivicay           | 10 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)                                    | 30 tablets  |
| EU/1/13/892/004  | Tivicay           | 10 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)                                    | 90 tablets  |
| EU/1/13/892/005  | Tivicay           | 25 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)                                    | 30 tablets  |
| EU/1/13/892/006  | Tivicay           | 25 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)                                    | 90 tablets  |
| EU/1/13/892/007  | Tivicay           | 5 mg       | Dispersible tablet    | Oral use                  | bottle (HDPE) + 1 measuring cup + 1 oral syringe | 60 tablets  |